I bet it's JPMorgan continuing their buying. They have been buying into Arc strongly over the last 2 weeks. I think corporate action is very close.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025